Voriconazole Intravenous (Iv) Solution 200 mg/100 mL Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Solution
Available Strengths: 200 mg/100 mL
Reference Brands: Vfend(US & EU)
Category: Anti-fungal
Voriconazole IV inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis essential for fungal cell membranes. It provides broad-spectrum antifungal activity, rapid systemic treatment, and excellent tissue penetration. Benefits include high efficacy against invasive fungi like Aspergillus, making it vital for treating severe fungal infections.
Product Description:
Voriconazole IV solution is approved in the EU and US for severe fungal infections. In the EU, Pfizer’s Vfend IV is regulated by EMA, backed by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continuous safety monitoring. For expert assistance with regulatory dossiers, submissions, and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory solutions. We support efficient market access for voriconazole IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Voriconazole Intravenous (Iv) Solution — third party manufacturing & bulk supply
Voriconazole Intravenous (Iv) Solution 200 mg/100 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Voriconazole Intravenous (Iv) Solution listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Voriconazole Intravenous (Iv) Solution →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Voriconazole is used to treat serious fungal infections, particularly invasive aspergillosis, candidemia, esophageal candidiasis, and infections caused by Scedosporium and Fusarium species. It is often prescribed for immunocompromised patients and is known for its broad-spectrum antifungal activity and strong efficacy.
Voriconazole contains the active triazole antifungal compound voriconazole. It is formulated with suitable pharmaceutical excipients designed to enhance absorption, stability, and bioavailability depending on the dosage form.
The main trade name for voriconazole is Vfend, widely marketed in the USA, EU, UK, and other global regions.
Vfend is manufactured by Pfizer. Generic versions of voriconazole are also produced by several GMP-certified manufacturers across different international markets.
The generic name is voriconazole.
The primary brand name is Vfend.
Voriconazole is manufactured in Pfizer’s regulated facilities in the USA and Europe, along with multiple GMP-approved pharmaceutical companies that produce generic voriconazole for global supply.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View Details
Terconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
